In addition, sFlt-1, the soluble receptor for VEGF and PlGF, has been reported to be decreased in serum and follicular fluid of PCOS women undergoing controlled ovarian stimulation, contributing to increased VEGF bioavailability [15]. The gene discussed is PGF; the disease is polycystic ovary syndrome.